| Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives C Vernieri, M Milano, M Brambilla, A Mennitto, C Maggi, MS Cona, ... Critical reviews in oncology/hematology 139, 53-66, 2019 | 194 | 2019 |
| The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer C Vernieri, A Mennitto, M Prisciandaro, V Huber, M Milano, L Rinaldi, ... Scientific reports 8 (1), 8703, 2018 | 58 | 2018 |
| Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world … L Cantini, G Mentrasti, GL Russo, D Signorelli, G Pasello, E Rijavec, ... ESMO open 7 (2), 100406, 2022 | 54 | 2022 |
| Patients selection for immunotherapy in solid tumors: overcome the naïve vision of a single biomarker D Signorelli, P Giannatempo, G Grazia, MM Aiello, F Bertolini, A Mirabile, ... BioMed research international 2019 (1), 9056417, 2019 | 54 | 2019 |
| Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-L1 … MS Cona, M Lecchi, S Cresta, S Damian, M Del Vecchio, A Necchi, ... Cancers 11 (2), 223, 2019 | 21 | 2019 |
| Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study G Mentrasti, L Cantini, P Vici, N D'Ostilio, N La Verde, R Chiari, V Paolucci, ... The Breast 65, 164-171, 2022 | 20 | 2022 |
| Alarming drop in early stage colorectal cancer diagnoses after COVID-19 outbreak: a real-world analysis from the Italian COVID-DELAY study G Mentrasti, L Cantini, C Zichi, N D’Ostilio, F Gelsomino, E Martinelli, ... The Oncologist 27 (9), e723-e730, 2022 | 19 | 2022 |
| Single-agent gemcitabine vs. carboplatin-gemcitabine in advanced breast cancer: a retrospective comparison of efficacy and safety profiles C Vernieri, M Prisciandaro, M Milano, MS Cona, C Maggi, M Brambilla, ... Clinical Breast Cancer 19 (2), e306-e318, 2019 | 18 | 2019 |
| Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy R Berardi, M Torniai, MS Cona, FL Cecere, R Chiari, V Guarneri, ... ESMO open 6 (2), 100053, 2021 | 17 | 2021 |
| A proposal of a “ready to use” COVID-19 control strategy in an oncology ward: utopia or reality? D Dalu, S Rota, MS Cona, AM Brambilla, S Ferrario, A Gambaro, L Meroni, ... Critical Reviews in Oncology/Hematology 157, 103168, 2021 | 13 | 2021 |
| The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic MS Cona, E Rulli, D Dalu, F Galli, S Rota, S Ferrario, N Tosca, A Gambaro, ... Supportive Care in Cancer 30 (2), 1115-1125, 2022 | 10 | 2022 |
| An overview of immune checkpoint inhibitors in breast cancer F Miglietta, MS Cona, MV Dieci, V Guarneri, N La Verde Exploration of Targeted Anti-tumor Therapy 1 (6), 452, 2020 | 9 | 2020 |
| Oral capecitabine-vinorelbine is associated with longer overall survival when compared to single-agent capecitabine in patients with hormone receptor-positive advanced breast … C Vernieri, M Prisciandaro, F Nichetti, R Lobefaro, G Peverelli, F Ligorio, ... Cancers 12 (3), 617, 2020 | 7 | 2020 |
| Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy? D Signorelli, M Macerelli, C Proto, M Vitali, MS Cona, F Agustoni, ... Tumori Journal 102 (1), 18-30, 2016 | 7 | 2016 |
| Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection N La Verde, A Riva, MS Cona, A Gabrieli, M Cattaneo, C Fasola, G Lipari, ... International journal of cancer 152 (4), 661-671, 2023 | 6 | 2023 |
| Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: A real-life study D Dalu, C Fasola, L Ammoni, D De Francesco, MS Cona, S Rota, ... Journal of Chemotherapy 33 (5), 342-347, 2021 | 6 | 2021 |
| Host-related factors in the interplay among inflammation, immunity and dormancy in breast Cancer recurrence and prognosis: An overview for clinicians L Ruggieri, A Moretti, R Berardi, MS Cona, D Dalu, C Villa, D Chizzoniti, ... International Journal of Molecular Sciences 24 (5), 4974, 2023 | 5 | 2023 |
| Antibody response to three‐dose anti‐SARS‐CoV‐2 mRNA‐vaccination in treated solid cancer patients D Dalu, M Tarkowski, L Ruggieri, MS Cona, A Gabrieli, D De Francesco, ... International Journal of Cancer 154 (8), 1371-1376, 2024 | 2 | 2024 |
| Clinical efficacy of the first two doses of anti‐SARS‐CoV‐2 mRNA vaccines in solid cancer patients MS Cona, A Riva, D Dalu, A Gabrieli, C Fasola, G Lipari, G Pozza, E Rulli, ... Cancer Medicine 12 (12), 12967-12974, 2023 | 2 | 2023 |
| Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a … L Cantini, G Mentrasti, GL Russo, D Signorelli, G Pasello, E Rijavec, ... ESMO open 7 (2), 2022 | 2 | 2022 |
